FDA.reportPublic FDA data

rezafungin 200 MG (as rezafungin acetate 210 MG) Injection

RxCUI
2639160
RxNorm name
rezafungin 200 MG (as rezafungin acetate 210 MG) Injection
Display name
rezafungin 200 MG (as rezafungin acetate 210 MG) Injection
Full name
rezafungin 200 MG (as rezafungin acetate 210 MG) Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
REZZAYOREZAFUNGINMelinta Therapeutics, LLC90073508-6dca-4d27-aa5a-ed837737c35b2026-07-01Warnings, Adverse reactionsExact identifier
rxcui: 2639160

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
90073508-6dca-4d27-aa5a-ed837737c35brezafungin 200 MG Injection [PSN] · rezafungin 200 MG Injection [SCD] · rezafungin 200 MG (as rezafungin acetate 210 MG) Injection [SY]34These highlights do not include all the information needed to use REZZAYO safely and effectively. See full prescribing information for REZZAYO. REZZAYO ® (rezafungin for injection), for intravenous use Initial U.S. Approval: 202320260312